Pharmacological effects and molecular mechanisms of action of a herbal medicine based on vitex agnus-castus
Dyshormonal breast dysplasia is the most frequent pathology encountered by practitioners. The interest of clinicians to these processes is associated with several factors. On the one hand effective treatment, relieves symptoms, ensures the quality of life. On the other hand, mastitis is a risk facto...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Publishing House TRILIST,
2018-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a0c0d532b6e24dddac1b0de3be1c0e2b | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a И. В. Высоцкая |e author |
| 700 | 1 | 0 | |a В. П. Летягин |e author |
| 245 | 0 | 0 | |a Pharmacological effects and molecular mechanisms of action of a herbal medicine based on vitex agnus-castus |
| 260 | |b Publishing House TRILIST, |c 2018-04-01T00:00:00Z. | ||
| 500 | |a 2309-4117 | ||
| 500 | |a 2411-1295 | ||
| 500 | |a 10.18370/2309-4117.2018.40.93-97 | ||
| 520 | |a Dyshormonal breast dysplasia is the most frequent pathology encountered by practitioners. The interest of clinicians to these processes is associated with several factors. On the one hand effective treatment, relieves symptoms, ensures the quality of life. On the other hand, mastitis is a risk factor for subsequent malignant tumor. Therefore, timely correction is a variant of primary prevention of breast cancer. The choice of the adequate tactics of conducting such patients from the existing diversity of dosage forms is the key to success. The paper discusses the main molecular mechanisms that are implemented with the use of the drug Mastodynon®. | ||
| 546 | |a EN | ||
| 546 | |a RU | ||
| 546 | |a UK | ||
| 690 | |a dishormonal dysplasia | ||
| 690 | |a mastalgia | ||
| 690 | |a mastopathy | ||
| 690 | |a mastodynia | ||
| 690 | |a hyperprolactinemia | ||
| 690 | |a opioid receptors | ||
| 690 | |a receptors to estrogens | ||
| 690 | |a dopamine receptors | ||
| 690 | |a mastodynon | ||
| 690 | |a Gynecology and obstetrics | ||
| 690 | |a RG1-991 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Репродуктивная эндокринология, Iss 40, Pp 93-97 (2018) | |
| 787 | 0 | |n http://reproduct-endo.com/article/view/131206 | |
| 787 | 0 | |n https://doaj.org/toc/2309-4117 | |
| 787 | 0 | |n https://doaj.org/toc/2411-1295 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a0c0d532b6e24dddac1b0de3be1c0e2b |z Connect to this object online. |